Late administration of luteinizing hormone-releasing hormone agonists, the impact on testosterone (T) suppression, and frequency of T and PSA testing in prostate cancer in the real-world

Releasing Hormone ◽

The Real ◽

Psa Testing ◽

The Impact

The Impact of Late Luteinizing Hormone-Releasing Hormone Agonist Dosing on Testosterone Suppression in Patients with Prostate Cancer: An Analysis of United States Clinical Data

The Journal of Urology ◽

10.1097/ju.0000000000000577 ◽

2020 ◽

Vol 203 (4) ◽

pp. 743-750

Author(s):

E. David Crawford ◽

Przemyslaw W. Twardowski ◽

Raoul S. Concepcion ◽

Jason M. Hafron ◽

Richard G. Harris ◽

...

Keyword(s):

Prostate Cancer ◽

United States ◽

Luteinizing Hormone ◽

Clinical Data ◽

Releasing Hormone ◽

The Impact

Faculty Opinions recommendation of Efficacy of a second line luteinizing hormone-releasing hormone agonist after advanced prostate cancer biochemical recurrence.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.14267095.15779304 ◽

2012 ◽

Author(s):

Hendrik van Poppel ◽

Yuri Tolkach

Keyword(s):

Prostate Cancer ◽

Luteinizing Hormone ◽

Biochemical Recurrence ◽

Advanced Prostate Cancer ◽

Second Line ◽

566 ANAMEM: Prospective and observational study to evaluate cognitive changes in prostate cancer patients undergoing luteinizing hormone-releasing hormone analogue treatment

European Urology Supplements ◽

10.1016/s1569-9056(15)60559-0 ◽

2015 ◽

Vol 14 (2) ◽

pp. e566-e566a

Author(s):

J. Morote ◽

A. Tabernero ◽

M.J. Ledo ◽

J.P. Ciria ◽

J.L. Domínguez-Escrig ◽

...

Keyword(s):

Prostate Cancer ◽

Luteinizing Hormone ◽

Observational Study ◽

Cancer Patients ◽

Hormone Analogue ◽

Cognitive Changes ◽

Cancer Treatment and Research - Endocrine Therapies in Breast and Prostate Cancer ◽

Luteinizing Hormone-Releasing Hormone Analogues in the Treatment of Prostate Cancer

10.1007/978-1-4613-1731-9_2 ◽

1988 ◽

pp. 25-38 ◽

Cited By ~ 3

Author(s):

E. David Crawford ◽

Marilyn A. Davis

Keyword(s):

Prostate Cancer ◽

Luteinizing Hormone ◽

Luteinizing Hormone-Releasing Hormone and Its Agonistic, Antagonistic, and Targeted Cytotoxic Analogs in Prostate Cancer

Drug Management of Prostate Cancer ◽

10.1007/978-1-60327-829-4_2 ◽

2010 ◽

pp. 27-39

Author(s):

Andrew V. Schally ◽

Norman L. Block

Keyword(s):

Prostate Cancer ◽

Luteinizing Hormone ◽

Luteinizing hormone-releasing hormone receptor targeted agents for prostate cancer

Expert Opinion on Investigational Drugs ◽

10.1517/13543784.2011.574611 ◽

2011 ◽

Vol 20 (6) ◽

pp. 769-778 ◽

Cited By ~ 21

Author(s):

Stephen V Liu ◽

Shanshan Liu ◽

Jacek Pinski

Keyword(s):

Prostate Cancer ◽

Luteinizing Hormone ◽

Hormone Receptor ◽

Targeted Agents ◽

Patient compliance in treatment of prostate cancer with luteinizing hormone-releasing hormone (LHRH) agonist

Urology ◽

10.1016/0090-4295(93)90265-c ◽

1993 ◽

Vol 42 (5) ◽

pp. 533-535 ◽

Cited By ~ 12

Author(s):

J.Anthony Shaheen ◽

Mohammad Amin ◽

James I. Harty

Keyword(s):

Prostate Cancer ◽

Luteinizing Hormone ◽

Patient Compliance ◽

Lhrh Agonist ◽

MP73-01 ANAMEM: PROSPECTIVE AND OBSERVATIONAL STUDY TO EVALUATE COGNITIVE CHANGES IN PROSTATE CANCER PATIENTS UNDERGOING LUTEINIZING HORMONE-RELEASING HORMONE ANALOGUE TREATMENT

The Journal of Urology ◽

10.1016/j.juro.2015.02.2677 ◽

2015 ◽

Vol 193 (4S) ◽

Author(s):

Juan Morote ◽

Ángel Tabernero ◽

José Luis Álvarez-Ossorio ◽

Juan Pablo Ciria ◽

José Luis Domínguez-Escrig ◽

...

Keyword(s):

Prostate Cancer ◽

Luteinizing Hormone ◽

Observational Study ◽

Cancer Patients ◽

Hormone Analogue ◽

Cognitive Changes ◽

A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancer

Urology ◽

10.1016/s0090-4295(99)80368-9 ◽

1995 ◽

Vol 46 (6) ◽

pp. 899 ◽

Cited By ~ 2

Author(s):

E. David Crawford

Keyword(s):

Prostate Cancer ◽

Luteinizing Hormone ◽

Advanced Prostate Cancer ◽

Controlled Trial ◽

Hormone Analogue ◽

MP87-04 EFFECT OF LUTEINIZING HORMONE-RELEASING HORMONE ANTAGONIST ON TESTOSTERONE RECOVERY AFTER NEOADJUVANT THERAPY WITH OR WITHOUT ADJUVANT ANDROGEN DEPRIVATION AND RADIOTHERAPY FOR LOCALIZED PROSTATE CANCER

The Journal of Urology ◽

10.1016/j.juro.2018.02.2904 ◽

2018 ◽

Vol 199 (4S) ◽

Author(s):

Junpei Iizuka ◽

Yasunobu Hashimoto ◽

Tsunenori Kondo ◽

Keisuke Hata ◽

Toshio Takagi ◽

...

Keyword(s):

Prostate Cancer ◽

Luteinizing Hormone ◽

Neoadjuvant Therapy ◽

Androgen Deprivation ◽

Localized Prostate Cancer ◽